Literature DB >> 3973012

Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger.

B F Kase, I Björkhem, P Hågå, J I Pedersen.   

Abstract

Based on in vitro work with rat liver, we recently suggested that the peroxisomal fraction is most important for the oxidation of 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 beta-cholestanoic acid (THCA) into cholic acid. The cerebro-hepato-renal syndrome of Zellweger is a fatal recessive autosomal disorder, the most characteristic histological feature of which is a virtual absence of peroxisomes in liver and kidneys. This disease offers a unique opportunity to evaluate the relative importance of peroxisomes in bile acid biosynthesis. A child with Zellweger syndrome was studied in the present work. In accordance with previous work, there was a considerable accumulation of THCA, 3 alpha, 7 alpha, 12 alpha, 24-tetrahydroxy-5 beta-cholestanoic acid (24-OH-THCA), 3 alpha, 7 alpha, 12 alpha-trihydroxy-27-carboxymethyl-5 beta-cholestan-26-oic acid (C29-dicarboxylic acid), and 3 alpha, 7 alpha-dihydroxy-5 beta-cholestanoic acid in serum. In addition, a tetrahydroxylated 5 beta-cholestanoic acid with all the hydroxyl groups in the steroid nucleus was found. 3H-Labeled 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol was administered intravenously together with 14C-labeled cholic acid. There was a rapid incorporation of 3H in THCA and a slow incorporation into cholic acid. The specific radioactivity of 3H in THCA was about one magnitude higher than that in cholic acid. The conversion was evaluated by following the increasing ratio between 3H and 14C in biliary cholic acid. The rate of incorporation of 3H in cholic acid was considerably less than previously reported in experiments with healthy subjects, and the maximal conversion of the triol into cholic acid was only 15-20%. About the same rate of conversion was found after oral administration of 3H-THCA. Both in the experiment with 3H-5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol and with 3H-THCA, there was an efficient incorporation of 3H in the above unidentified tetrahydroxylated 5 beta-cholestanoic acid. There was only slow incorporation of radioactivity into 24-OH-THCA and into the C29-dicarboxylic acid. From the specific activity decay curve of 14C in cholic acid obtained after intravenous injection of 14C-cholic acid, the pool size of cholic acid was calculated to be 24 mg/m2 and the daily production rate to 9 mg/m2 per d. This corresponds to a reduction of approximately 85 and 90%, respectively, when compared with normal infants. It is concluded that liver peroxisomes are essential in the normal conversion of THCA to cholic acid. In the Zellweger syndrome this conversion is defective and as a consequence the accumulated THCA is either excreted as such or transformed into other metabolites by hydroxylation or side chain elongation. The accumulation of THCA, as well as the similar rate of conversion of 5 beta-cholestane-3 alpha,7 alpha.12 alpha-triol and THCA into cholic acid, support the contention that the 26-hydroxylase pathway with intermediate formation of THCA is the most important pathway for formation of cholic acid in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3973012      PMCID: PMC423512          DOI: 10.1172/JCI111717

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Metabolism of 3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholestan-26-oic acid in normal subjects with an intact enterohepatic circulation.

Authors:  R F Hanson; G C Williams
Journal:  J Lipid Res       Date:  1977-09       Impact factor: 5.922

2.  Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome.

Authors:  S Goldfischer; C L Moore; A B Johnson; A J Spiro; M P Valsamis; H K Wisniewski; R H Ritch; W T Norton; I Rapin; L M Gartner
Journal:  Science       Date:  1973-10-05       Impact factor: 47.728

3.  Trihydroxycoprostanic acid in the duodenal fluid of two children with intrahepatic bile duct anomalies.

Authors:  H Eyssen; G Parmentier; F Compernolle; J Boon; E Eggermont
Journal:  Biochim Biophys Acta       Date:  1972-06-26

4.  Bile salt metabolism in the human premature infant. Preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital.

Authors:  J B Watkins; P Szczepanik; J B Gould; P Klein; R Lester
Journal:  Gastroenterology       Date:  1975-09       Impact factor: 22.682

5.  The mechanism of arrest of neuronal migration in the Zellweger malformation: an hypothesis bases upon cytoarchitectonic analysis.

Authors:  P Evrard; V S Caviness; J Prats-Vinas; G Lyon
Journal:  Acta Neuropathol       Date:  1978-02-20       Impact factor: 17.088

6.  Omega-hydroxylation of steriod side-chain in biosynthesis of bile acids.

Authors:  I Björkhem; J Gustafsson
Journal:  Eur J Biochem       Date:  1973-07-02

7.  Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids.

Authors:  F R Brown; A J McAdams; J W Cummins; R Konkol; I Singh; A B Moser; H W Moser
Journal:  Johns Hopkins Med J       Date:  1982-12

8.  High concentration of hexacosanoate in cultured skin fibroblast lipids from adrenoleukodystrophy patients.

Authors:  N Kawamura; A B Moser; H W Moser; T Ogino; K Suzuki; H Schaumburg; A Milunsky; J Murphy; Y Kishimoto
Journal:  Biochem Biophys Res Commun       Date:  1978-05-15       Impact factor: 3.575

9.  The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis.

Authors:  R F Hanson; J N Isenberg; G C Williams; D Hachey; P Szczepanik; P D Klein; H L Sharp
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

10.  A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.

Authors:  S Shefer; F W Cheng; B Dayal; S Hauser; G S Tint; G Salen; E H Mosbach
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

View more
  13 in total

1.  Di- and trihydroxycholestanaemia in twin sisters.

Authors:  R J Wanders; C W van Roermund; A Schelen; R B Schutgens; J Zeman; V Kozich; J Hyanek; M Casteels; G P Mannaerts
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Two Major Bile Acids in the Hornbills, (24R,25S)-3α,7α,24-Trihydroxy-5β-cholestan-27-oyl Taurine and Its 12α-Hydroxy Derivative.

Authors:  Rika Satoh; Hiroaki Ogata; Tetsuya Saito; Biao Zhou; Kaoru Omura; Satoshi Kurabuchi; Kuniko Mitamura; Shigeo Ikegawa; Lee R Hagey; Alan F Hofmann; Takashi Iida
Journal:  Lipids       Date:  2016-04-23       Impact factor: 1.880

Review 3.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  Bile acid profiles in peroxisomal 3-oxoacyl-coenzyme A thiolase deficiency.

Authors:  P T Clayton; E Patel; A M Lawson; R A Carruthers; J Collins
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 5.  Peroxisomal disorders: a newly recognised group of genetic diseases.

Authors:  R B Schutgens; H S Heymans; R J Wanders; H van den Bosch; J M Tager
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

6.  Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome).

Authors:  P B Lazarow; Y Fujiki; G M Small; P Watkins; H Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: identification by means of complementation analysis.

Authors:  Y Suzuki; N Shimozawa; S Yajima; S Tomatsu; N Kondo; Y Nakada; S Akaboshi; M Lai; Y Tanabe; T Hashimoto
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

8.  Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.

Authors:  U Diczfalusy; B F Kase; S E Alexson; I Björkhem
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Plasma bile acids in patients with peroxisomal dysfunction syndromes: analysis by capillary gas chromatography-mass spectrometry.

Authors:  P T Clayton; B D Lake; N A Hall; D B Shortland; R A Carruthers; A M Lawson
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.